Elsevier invites researchers and data scientists focused on Coronavirus and COVID-19 vaccines and drugs, as well as clinical research, to access this Elsevier provides solutions and Tools for free to their work through Elsevier Coronavirus Research Hub.
This scheme offering a collection of clinical, bio-medical and life sciences research resources and solutions to the community for free, for Coronavirus research through 28th of October 2020. These services may be used by academic, government, not-for-profit and commercial researchers.
Elsevier will initially give priority access to researchers working on a vaccine, drug, and clinical research while we are working hard to increase the capacity and capabilities of the platform for further use cases.
Elsevier Coronavirus Research Hub
The Elsevier Coronavirus Research Hub will include access to ClinicalKey, Embase, SSRN, Mendeley Data, the Science Direct Covid-19 collection, Elsevier Text Mining (ETM), Mendeley and the Pure Covid-19 Portal.
Covid-19 Research Database
The COVID-19 research database is a collection of de-identified data sets made freely available to public health and policy researchers to extract insights for combatting the COVID-19 pandemic.
The database is a pro-bono, cross-industry collaboration composed of a consortium of institutions that have contributed data, technology services, health sector knowledge.
Until now, researchers and policy-makers seeking to answer questions about the pandemic could only conduct research on fragmented data sets (such as the data set from a particular hospital), or to conduct long, prospective clinical trials, which makes it difficult to rapidly answer questions about the epidemiology and treatment of the disease.
Various Segments of Elsevier Coronavirus Research Hub
Life Sciences : Empowering your exploration and delivery of diagnostic, therapeutic, and preventive interventions.
Clinical Research:Empowering you to manage population and patient health, and to capture and share clinical data.
Academic & Government:Empowering you with the latest published data and insights, and enabling cross-sector collaboration.
Data Scientist:Empowering you to more quickly gather and operationalize your training sets and models with quality data.
Free Access to Elsevier Tools:
ClinicalKey: Find and apply the current clinical understanding of coronavirus related pathophysiology, diagnosis and treatment.
Embase: Surface drug-disease relationships, drug-drug interactions, treatments used in similar pathologies, and suitable animal models for testing.
SSRN: Quickly find up-to-the-minute research on Covid-19 via this open-access online preprint community.
Pure: Identify potential research collaborators in areas related to the coronavirus epidemic across basic science, translational research, or clinical practice.
Mendeley: Organize your COVID-19 research, collaborate with others online, and discover the latest research
Mendeley Data: Discover, collect, share and publish COVID-19 research data
Text Mining: Find precise biomedical information from > 14 million full-text articles from multiple publishers, in addition to smarter searching and interrogation of the CORD-19 dataset.
ScienceDirect: Build your knowledge of the emerging research; assess the methods and evidence found in >24,000 novel coronavirus and Covid-19 related full-text articles.
Professional Services: Obtain full drug candidate profiles, analyzed and ranked based on your submitted criteria.
Pathway Studio: In Mendeley Data investigate biological relationships between diseases (MERS and SARS), proteins and molecules, all extracted from Pathway Studio.
How to Apply
You can apply by using academic, institutional, or corporate email account for registration. There may be delays or further accreditation necessary if you use a non-institutional email account.
If you register without an institutional email account, we may ask you for endorsement by a department head listed on the institution’s public website through her/his institutional email account.
You can test the system and set up your study immediately but we should sign a data processing agreement before you begin to collect patient data.
The application process may take up to 72 hours to complete.
